COVID-19 and the heart: An update for clinicians.

Clinical Cardiology
Ahmed GohaErnest Madu

Abstract

SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and indirectly with clinical syndromes of acute myocardial injury, myocarditis, acute coronary syndromes, heart failure, arrhythmias, and venous thromboembolism. Some therapeutics under investigation for COVID-19 may also have adverse cardiac effects. The involvement of the RAAS system in viral entry makes it pertinent to consider the effects of medications that modulate the system. Comprehensive knowledge of peculiar cardiovascular manifestations of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is needed for optimal patient management.

References

Jul 22, 2016·JAMA Cardiology·Jennifer L NguyenPatrick L Kinney
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 4, 2020·JAMA : the Journal of the American Medical Association·Barnaby Edward YoungUNKNOWN Singapore 2019 Novel Coronavirus Outbreak Research Team
Mar 18, 2020·Circulation. Cardiovascular Quality and Outcomes·Chor-Cheung Frankie TamChung-Wah Siu
Mar 19, 2020·European Heart Journal·Tian-Yuan XiongMao Chen
Mar 24, 2020·Circulation·Kevin J ClerkinNir Uriel
Mar 28, 2020·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN CDC COVID-19 Response Team
Apr 5, 2020·Diabetes & Metabolic Syndrome·Manish Bansal
Apr 7, 2020·International Journal of Cardiology·Weiyi Tan, Jamil Aboulhosn
Apr 8, 2020·Circulation Research·Akbarshakh Akhmerov, Eduardo Marban
Apr 8, 2020·Proceedings of the National Academy of Sciences of the United States of America·Kai DuanXiaoming Yang
Apr 8, 2020·Pharmacotherapy·Ashley BarlowMojdeh S Heavner
Apr 16, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sufang TianShu-Yuan Xiao
Apr 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Litao ZhangZhenlu Zhang
Apr 21, 2020·International Journal of Stroke : Official Journal of the International Stroke Society·Gaurav AggarwalBrandon Michael Henry
Apr 23, 2020·JAMA : the Journal of the American Medical Association·Safiya RichardsonTheodoros P Zanos
Apr 28, 2020·JAMA : the Journal of the American Medical Association·Travis P BaggettJessie M Gaeta
May 2, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Rahma BeyroutiDavid J Werring
May 11, 2020·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Bhurint SiripanthongC Anwar A Chahal
May 14, 2020·Archives of Medical Science : AMS·Željko ReinerAmirhossein Sahebkar
Aug 25, 2020·The Lancet Rheumatology·Dennis McGonagleCharles Bridgewood

❮ Previous
Next ❯

Citations

Nov 12, 2020·Clinical Cardiology·Jawahar L MehtaPier P Bassareo
Nov 25, 2020·ESC Heart Failure·Sarah J CharmanDjordje G Jakovljevic
Mar 31, 2021·Gut and Liver·Jeong Eun SongUNKNOWN Daegu-Gyeongbuk Liver Study Group (DGLSG)
Dec 31, 2021·Current Opinion in Urology·Justin M DubinJoshua A Halpern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

The American Journal of the Medical Sciences
Wei-Ting ChangWen-Liang Yu
The Indian Journal of Medical Research
Yash Paul SharmaAnkur Gupta
The Indian Journal of Medical Research
Yash Paul SharmaAnkur Gupta
Cardiovascular Drugs and Therapy
Azita Hajhossein TalasazBabak Geraiely
The New England Journal of Medicine
Martin H StraussCarl J Lavie
© 2022 Meta ULC. All rights reserved